However, the phosphorylation of ERK1/2 and AKT in NL20 was not affected (Figure S11B), which suggested that AHCYL1 might employ distinct regulatory mechanisms for cell growth in normal versus lung cancer cellular contexts. The gene discussed is MAPK3; the disease is lung cancer.